Skip to content

Study on the Application Effect of Patient-Controlled Intravenous Analgesia with Tramadol in Gynecological Laparoscopic Surgery

Study on the Application Effect of Patient-Controlled Intravenous Analgesia with Tramadol in Gynecological Laparoscopic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109661
Enrollment
Unknown
Registered
2025-09-23
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain after gynecological laparoscopic surgery

Interventions

Sufentanil (S) group:Background dose 2mL/h, PCA dose 0.5ml (0.75µg), lock time 15min
Taijili Group (T):Load amount 1mg (to be completed within 10 minutes), PCA dose 1ml (0.05mg), lock time 10 minutes

Sponsors

Longgang Central Hospital, Shenzhen City
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Age 18~65; 2. Plan to undergo laparoscopic gynecological surgery; 3. ASA physical status classification I~II.

Exclusion criteria

Exclusion criteria: 1. Use of antiemetics or anticholinergic drugs before surgery; 2. Long-term use of sedatives, analgesics, or antipsychotic medications; 3. History of severe nausea and vomiting or severe motion sickness before surgery; 4. Presence of serious conditions, including severe liver and kidney dysfunction, autoimmune diseases, immunodeficiency, cardiovascular diseases, hematological diseases, etc.; 5. Chronic pain, neurological or mental disorders; 6. Poor compliance, difficulty in cooperating with treatment and follow-up.

Design outcomes

Primary

MeasureTime frame
The incidence of PONV within 48 hours;

Countries

China

Contacts

Public ContactHongyi Lei

Longgang Central Hospital, Shenzhen City

shaoym24@163.com+86 188 6670 0628

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026